The FDA Biologics Effectiveness and Safety (BEST) Initiative
The U.S. Food & Drug Administration (FDA) needs to make decisions on drug and vaccine safety and effectiveness with confidence. As a key collaborator, Optum Epidemiology generates reproducible results that inform decisions for COVID-19 vaccines. Learn more at bestinitiative.org.
Related healthcare insights
E-book
Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.